{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:16:05Z","timestamp":1788466565176,"version":"build-2803163510"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1093\/carcin\/bgs276","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T04:49:01Z","timestamp":1346820541000},"page":"2424-2431","source":"Crossref","is-referenced-by-count":52,"title":["Prevention of liver carcinogenesis by amarogentin through modulation of G 1 \/S cell cycle check point and induction of apoptosis"],"prefix":"10.1093","volume":"33","author":[{"given":"Debolina","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhayan","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvra","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashes","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukta","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay Kumar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,9,3]]},"reference":[{"key":"key\n\t\t\t\t20170521000257_CIT0001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3322\/canjclin.45.1.31","article-title":"Chemoprevention.","volume":"45","author":"Greenwald","year":"1995","journal-title":"CA. Cancer J. Clin ."},{"key":"key\n\t\t\t\t20170521000257_CIT0002","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ptr.2738","article-title":"Assessment of systemic interaction between Swertia chirata extract and its Bioactive constituents in rabbits.","volume":"23","author":"Suryawanshi","year":"2009","journal-title":"Phytother. Res ."},{"key":"key\n\t\t\t\t20170521000257_CIT0003","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ptr.1436","article-title":"Evaluation of the anticarcinogenic activity of Swertia chirata Buch.Ham, an Indian medicinal plant, on DMBA-induced mouse skin carcinogenesis model.","volume":"18","author":"Saha","year":"2004","journal-title":"Phytother. Res ."},{"key":"key\n\t\t\t\t20170521000257_CIT0004","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment.","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170521000257_CIT0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2168.2001.01732.x","article-title":"Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.","volume":"88","author":"Nagasue","year":"2001","journal-title":"Br. J. Surg ."},{"key":"key\n\t\t\t\t20170521000257_CIT0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-8278(00)80412-2","article-title":"Liver regeneration","volume":"32","author":"Fausto","year":"2000","journal-title":"J. Hepatol."},{"key":"key\n\t\t\t\t20170521000257_CIT0007","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3748\/wjg.v17.i25.3043","article-title":"P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis.","volume":"17","author":"Zang","year":"2011","journal-title":"World J. Gastroenterol ."},{"key":"key\n\t\t\t\t20170521000257_CIT0008","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/01926230590522130","article-title":"Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.","volume":"33","author":"Kim","year":"2005","journal-title":"Toxicol. Pathol ."},{"key":"key\n\t\t\t\t20170521000257_CIT0009","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/94.2.129","article-title":"Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis.","volume":"94","author":"Plath","year":"2002","journal-title":"J. Natl. Cancer Inst ."},{"key":"key\n\t\t\t\t20170521000257_CIT0010","first-page":"4096","article-title":"Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas.","volume":"6","author":"Shi","year":"2000","journal-title":"Clin. Cancer Res ."},{"key":"key\n\t\t\t\t20170521000257_CIT0011","doi-asserted-by":"crossref","first-page":"e19758","DOI":"10.1371\/journal.pone.0019758","article-title":"Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinoma.","volume":"6","author":"Saddic","year":"2011","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170521000257_CIT0012","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.semcancer.2006.07.015","article-title":"The Myc oncoprotein as a therapeutic target for human cancer.","volume":"16","author":"Vita","year":"2006","journal-title":"Semin. Cancer Biol ."},{"key":"key\n\t\t\t\t20170521000257_CIT0013","first-page":"123","article-title":"Disruption of the pRb\/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.","volume":"58","author":"Santoni-Rugiu","year":"1998","journal-title":"Cancer Res ."},{"key":"key\n\t\t\t\t20170521000257_CIT0014","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-6-24","article-title":"The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention.","volume":"6","author":"Alao","year":"2007","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t20170521000257_CIT0015","first-page":"1764","article-title":"Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.","volume":"9","author":"Xu","year":"2003","journal-title":"Clin. Cancer Res ."},{"key":"key\n\t\t\t\t20170521000257_CIT0016","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1479-5876-7-110","article-title":"Correlation between expression of p53, p21\/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.","volume":"7","author":"Zhang","year":"2009","journal-title":"J. Transl. Med."},{"key":"key\n\t\t\t\t20170521000257_CIT0017","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3748\/wjg.14.1734","article-title":"Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.","volume":"14","author":"Matsuda","year":"2008","journal-title":"World J. Gastroenterol ."},{"key":"key\n\t\t\t\t20170521000257_CIT0018","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.510250314","article-title":"Reduced p21(WAF1\/CIP1) expression and p53 mutation in hepatocellular carcinomas.","volume":"25","author":"Hui","year":"1997","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170521000257_CIT0019","doi-asserted-by":"crossref","first-page":"52890","DOI":"10.1074\/jbc.M300279200","article-title":"Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.","volume":"278","author":"Knights","year":"2003","journal-title":"J. Biol. Chem ."},{"key":"key\n\t\t\t\t20170521000257_CIT0020","doi-asserted-by":"crossref","first-page":"16531","DOI":"10.1073\/pnas.0407123101","article-title":"LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription.","volume":"101","author":"Sharp","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A ."},{"key":"key\n\t\t\t\t20170521000257_CIT0021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2407-10-75","article-title":"Simultaneous down-regulation of tumor suppressor genes RBSP3\/CTDSPL, NPRL2\/G21 and RASSF1A in primary non-small cell lung cancer.","volume":"10","author":"Senchenko","year":"2010","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t20170521000257_CIT0022","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.canlet.2008.03.015","article-title":"Cell cycle regulated phosphorylation of LIMD1 in cell lines and expression in human breast cancers.","volume":"267","author":"Huggins","year":"2008","journal-title":"Cancer Lett ."},{"key":"key\n\t\t\t\t20170521000257_CIT0023","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1349-7006.2008.00952.x","article-title":"Frequent alterations of hMLH1 and RBSP3\/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance.","volume":"99","author":"Sinha","year":"2008","journal-title":"Cancer Sci."},{"key":"key\n\t\t\t\t20170521000257_CIT0024","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1349-7006.2010.01551.x","article-title":"Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance.","volume":"101","author":"Ghosh","year":"2010","journal-title":"Cancer Sci ."},{"key":"key\n\t\t\t\t20170521000257_CIT0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1476-4598-9-58","article-title":"LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications.","volume":"9","author":"Ghosh","year":"2010","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t20170521000257_CIT0026","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4161\/cc.1.3.117","article-title":"Phytochemicals as cell cycle modulators: a less toxic approach in halting human cancers.","volume":"1","author":"Singh","year":"2002","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170521000257_CIT0027","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/jnci\/djh123","article-title":"Apoptosis as a novel target for cancer chemoprevention.","volume":"96","author":"Sun","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"key\n\t\t\t\t20170521000257_CIT0028","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.68.1.383","article-title":"Mammalian caspases: structure, activation, substrates, and functions during apoptosis.","volume":"68","author":"Earnshaw","year":"1999","journal-title":"Annu. Rev. Biochem ."},{"key":"key\n\t\t\t\t20170521000257_CIT0029","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2005.12.036","article-title":"Amarogentin can reduce hyperproliferation by downregulation of Cox-II and upregulation of apoptosis in mouse skin carcinogenesis model.","volume":"244","author":"Saha","year":"2006","journal-title":"Cancer Lett ."},{"key":"key\n\t\t\t\t20170521000257_CIT0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0006-291X(03)00615-6","article-title":"Mechanisms of cytochrome c release by proapoptotic BCL-2 family members.","volume":"304","author":"Scorrano","year":"2003","journal-title":"Biochem. Biophys. Res. Commun ."},{"key":"key\n\t\t\t\t20170521000257_CIT0031","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1615\/JEnvPathToxOncol.v23.i4.50","article-title":"Protective effect of diphenylmethyl selenocyanate against carbon tetrachloride-induced hepatotoxicity in vivo .","volume":"23","author":"Das","year":"2004","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"key\n\t\t\t\t20170521000257_CIT0032","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/carcin\/20.1.59","article-title":"Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.","volume":"20","author":"Shiota","year":"1999","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170521000257_CIT0033","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key\n\t\t\t\t20170521000257_CIT0034","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1158\/1078-0432.CCR-06-1759","article-title":"Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.","volume":"12","author":"Perrone","year":"2006","journal-title":"Clin. Cancer Res ."},{"key":"key\n\t\t\t\t20170521000257_CIT0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.2930490305","article-title":"Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival.","volume":"49","author":"Izumi","year":"1992","journal-title":"J. Surg. Oncol ."},{"key":"key\n\t\t\t\t20170521000257_CIT0036","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/jac\/44.6.791","article-title":"Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms.","volume":"44","author":"Medda","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"key\n\t\t\t\t20170521000257_CIT0037","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1128\/MCB.17.10.5771","article-title":"Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.","volume":"17","author":"Knudsen","year":"1997","journal-title":"Mol. Cell. Biol ."},{"key":"key\n\t\t\t\t20170521000257_CIT0038","doi-asserted-by":"crossref","first-page":"e28103","DOI":"10.1371\/journal.pone.0028103","article-title":"Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1\/S cell cycle proteins.","volume":"6","author":"Noh","year":"2011","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170521000257_CIT0039","first-page":"25","article-title":"Disruption of p53-p21\/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma.","volume":"12","author":"Lee","year":"2004","journal-title":"Oncol. Rep."},{"key":"key\n\t\t\t\t20170521000257_CIT0040","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3748\/wjg.v17.i25.3043","article-title":"P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis","volume":"17","author":"Zang","year":"2011","journal-title":"World J. Gastroenterol"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/33\/12\/2424\/17290215\/bgs276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T23:01:32Z","timestamp":1714345292000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgs276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,3]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,9,3]]},"published-print":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgs276","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,3]]}}}